Coversyl Plus Tablet 4+1.25mg Indications
Coversyl Plus Tablet 4 1.25mg is primarily indicated in conditions like Essential hypertension, Hypertension, Oedema in congestive heart failure, Oedema in pregnancy.
The severe or irreversible adverse effects of Coversyl Plus Tablet 4 1.25mg, which give rise to further complications include Hypokalemia, Hypercalcemia, Increased BUN (blood urea nitrates), Hyperuricemia, Hypoglycemia, Flaccid paralysis.,Coversyl Plus Tablet 4 1.25mg produces potentially life-threatening effects which include Coma, Cardiac Arrest, Cardiac arrest. which are responsible for the discontinuation of Coversyl Plus Tablet 4 1.25mg therapy.,The signs and symptoms that are produced after the acute overdosage of Coversyl Plus Tablet 4 1.25mg include Respiratory depression, Hypokalemia, Respiratory depression, Nausea & vomiting, Hyperuricemia, Muscle fatigue, Weakness, Respiratory depression, Acute gout., The symptomatic adverse reactions produced by Coversyl Plus Tablet 4 1.25mg are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Fatigue, Fever, Blurred vision, Skin rash, Agitation, Lassitude, Bleeding, dizziness.
Coversyl Plus Tablet 4 1.25mg is contraindicated in conditions like Renal failure, Hepatic failure, Hypersensitivity.
Use Coversyl Plus Tablet 4 1.25mg, with caution in patients with history of heart rhythm problems, diabetes, gout, kidney, thyroid, parathyroid or liver disease, systemic Lupus erythematosus (SLE) or an allergy to sulfa drugs. Coversyl Plus Tablet 4 1.25mg should not be used during pregnancy or lactation. It should be used with caution in patients with high blood pressure. Electrolyte imbalance should be corrected before the administration of Coversyl Plus Tablet 4 1.25mg. Elderly Should take low dose.